Xvivo Perfusion AB
STO:XVIVO
Wall Street
Price Targets
XVIVO Price Targets Summary
Xvivo Perfusion AB
According to Wall Street analysts, the average 1-year price target for
XVIVO
is 345.37 SEK
with a low forecast of 277.75 SEK and a high forecast of 428.4 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is XVIVO's stock price target?
Price Target
345.37
SEK
According to Wall Street analysts, the average 1-year price target for
XVIVO
is 345.37 SEK
with a low forecast of 277.75 SEK and a high forecast of 428.4 SEK.
What is Xvivo Perfusion AB's Revenue forecast?
Projected CAGR
27%
For the last 12 years the
compound annual growth rate for
Xvivo Perfusion AB's revenue is
23%.
The projected
CAGR
for the next 2 years is
27%.
What is Xvivo Perfusion AB's Operating Income forecast?
Projected CAGR
71%
For the last 12 years the
compound annual growth rate for
Xvivo Perfusion AB's operating income is
19%.
The projected
CAGR
for the next 2 years is
71%.
What is Xvivo Perfusion AB's Net Income forecast?
Projected CAGR
197%
For the last 12 years the
compound annual growth rate for
Xvivo Perfusion AB's net income is
10%.
The projected
CAGR
for the next 2 years is
197%.
